世界のHCS（High Content Screening：バイオ産業）市場動向と予測（～2018）...市場調査レポートについてご紹介

Table Of Contents

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Crackdown and Data Triangulation
1.6.3 Market Share
1.6.4 Key Data Points From Primary Sources
1.6.5 Key Data Points From Secondary Sources

2 Executive Summary (Page No. – 25)

3 Market Overview (Page No. – 29)
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Need For Determining Level of Toxicity in the Early Stages of Drug Discovery
3.3.1.2 Government Funding and Venture Capital Investments in Cell-Based Research Will Drive the Market Growth
3.3.1.3 Introduction of Enhanced Informatics Solutions and Improved Image Analysis Instruments
3.3.2 Restraints
3.3.2.1 High Cost of High Content Screening Systems May Hinder the Market Growth
3.3.3 Opportunities
3.3.3.1 Contract Research Organizations Have Significant Opportunities To Provide HCS Services
3.3.3.2 Adoption of High Content Screening For Primary Screening
3.3.3.3 Application of High Content Screening in Personalized Medicine
3.3.3.4 Collaborations To Increase Innovation in the HCS Market
3.3.4 Challenges
3.3.4.1 Shortage of Knowledgeable and Skilled Professionals For High Content Screening
3.4 Market Share Analysis

4 By Product Type (Page No. – 41)
4.1 Introduction
4.2 Instruments
4.2.1 Cell Imaging and Analysis Systems
4.2.2 Flow Cytometers
4.3 Consumables
4.3.1 Reagents & Assay Kits
4.3.2 Microplates
4.3.3 Other Consumables
4.4 Software
4.5 Services

5 By Application (Page No. – 60)
5.1 Introduction
5.1.1 Target Identification and Validation
5.1.2 Primary Screening and Secondary Screening
5.1.3 Toxicity Studies
5.1.4 Compound Profiling
5.1.5 Other Applications

6 By End Users (Page No. – 71)
6.1 Pharmaceutical and Biotechnology Companies
6.2 Academia and Government Institutes
6.3 Contract Research Organizations (CRO)

7 Geographic Analysis (Page No. – 80)
7.1 Introduction
7.2 North America
7.3 Europe
7.4 Asia
7.5 ROW

8 Competitive Landscape (Page No. – 103)
8.1 Introduction
8.2 New Product Launch
8.3 Expansions
8.4 Agreements, Collabarations, Partnerships
8.5 Acquisitions

9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 114)
9.1 Becton, Dickinson and Company
9.2 Cell Signaling Technology, Inc.
9.3 Danaher Corporation
9.4 Ge Healthcare (Subsidiary of General Electric Company)
9.5 Genedata Ag
9.6 Merck Kgaa
9.7 Perkinelmer, Inc.
9.8 thermo Fisher Scientific, Inc.
9.9 Thorlabs, Inc.
9.10 Yokogawa Electric Corporation

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.